EMREA — Easternmed Real Estate Capital Income Statement
0.000.00%
- €715.95m
- €698.03m
- £22.30m
- 55
- 33
- 35
- 31
Annual income statement for Easternmed Real Estate Capital, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 September 30th | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 42 W | 12 M | 9 M | 6 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.61 | 30 | 18.7 | 12.3 | 22.3 |
Cost of Revenue | |||||
Gross Profit | 5.39 | 22.1 | 17.1 | 11.1 | 17.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.35 | 37 | -1.34 | 4.58 | 29.7 |
Operating Profit | 7.26 | -7.07 | 20.1 | 7.73 | -7.42 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.89 | -7.82 | 19.7 | 7.85 | -7.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.64 | -12.7 | 16 | 6.05 | -10.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.64 | -12.7 | 16 | 6.05 | -10.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.64 | -12.7 | 16 | 6.05 | -10.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.009 | -0.02 | 0.021 | 0.009 | -0.017 |
Dividends per Share |